ACM
ELDN icon

ADAR1 Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History

ADAR1 Capital Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Sell
647,812
-326,609
-34% -$1.19M 0.12% 132
2026
Q1 		$3M Sell
974,421
-847,391
-47% -$2M 0.18% 107
2025
Q4 		$2.75M Buy
+1,821,812
New +$4.33M 0.2% 86
2025
Q3 		– Sell
-16,900
Closed -$45.8K – 233
2025
Q2 		$45.8K Buy
16,900
+300
+2% +$900 0.01% 192
2025
Q1 		$56.3K Buy
16,600
+600
+4% +$2.47K 0.01% 179
2024
Q4 		$65.9K Buy
+16,000
New +$63.1K 0.01% 190

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

ADAR1 Capital Management's ELDN Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Eledon Pharmaceuticals (ELDN) stake by 34% in Q2 2026, selling an estimated $1.19M and leaving 647,812 shares worth $2.55M. The position accounts for 0.12% of the portfolio, ranked #132.

ADAR1 Capital Management first reported a position in ELDN in Q4 2024 and has held it in 6 quarters since. The position peaked at $3M in Q1 2026. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • ADAR1 Capital Management held 647,812 shares of Eledon Pharmaceuticals worth $2.55M as of Q2 2026.
  • ADAR1 Capital Management sold 326,609 Eledon Pharmaceuticals shares in Q2 2026, an estimated $1.19M.
  • Eledon Pharmaceuticals made up 0.12% of ADAR1 Capital Management's portfolio in Q2 2026, its #132 holding.
  • ADAR1 Capital Management first reported a position in Eledon Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • ADAR1 Capital Management's Eledon Pharmaceuticals position peaked at $3M in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.